Gilead Sciences News
Most Popular Gilead Sciences Story
Pfizer, Roche suffer as big drugs falter
Today's earnings roundup is a snapshot of pharma's challenges--generic... Read more...
Latest Headlines
- October 21, 2009
- October 12, 2009
- August 13, 2009
- May 29, 2009
- May 15, 2009
- April 27, 2009
- April 22, 2009
- April 22, 2009
- February 13, 2009
- December 15, 2008
- November 4, 2008
- September 2, 2008
- August 12, 2008
- May 29, 2008
- April 28, 2008
- April 17, 2008
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
